Tagworks Pharmaceuticals

Tagworks Pharmaceuticals

Private
Nijmegen, GelderlandHealthcare & Life Scienceshttps://www.tagworkspharma.com

Last Round

Series A

Jun 22, 2023

Total Funding Raised

$65M

Momentum Score

25 /100

Company Overview

Tagworks is a biotechnology company specializing in antibody-based imaging and therapy solutions that enhance the effectiveness of cancer treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

click-to-releaseantibody-drug conjugatesADCin-vivo click chemistryprecision oncologyclick chemistryradiopharmaceuticalsradiopharmacontrolled drug releasesolid tumor therapynext-gen ADCnon-internalizing targetsradioimmunotherapyin-vivo drug activationdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tagworks Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tagworks Pharmaceuticals Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2023
SeedNov 27, 2021

Tagworks Pharmaceuticals Investors

Notable investors and investment history

InvestorRounds
BIF PartnersSeed, Series A
New Enterprise Associates (NEA)Series A
Lightstone VenturesSeries A
Ysios CapitalSeries A
Gilde HealthcareSeries A
MeneldorSeries A, Seed
Oost NLSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2025

    CSO to present on ADC platform at R&D Symposium on Antibody Conjugates.

  • Apr 23, 2025

    Keith Orford, MD, PhD, appointed as new CMO.

Tagworks Pharmaceuticals Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tagworks Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tagworks Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersNijmegen, Gelderland
Employee Range47
Year Founded2011
Last FundingJun 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.